(Q34463840)

2 August 2017

1 reference

title

Progress in prostate cancer chemoprevention: modulators of promotion and progression (English)

1 reference

2 August 2017

1 reference

Lieberman R

1

1 reference

2 August 2017

Bermejo C

2

1 reference

2 August 2017

Akaza H

3

1 reference

2 August 2017

Greenwald P

4

1 reference

2 August 2017

Fair W

5

1 reference

2 August 2017

Thompson I

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

58

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

835-842

1 reference

Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Strategies for chemoprevention of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

New opportunities for uncovering the molecular basis of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

STUDIES ON PROSTATIC CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Design of the Prostate Cancer Prevention Trial (PCPT).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Intake of carotenoids and retinol in relation to risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-1-integrin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Effects of increasing doses of 1 alpha-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Surrogate endpoints in clinical trials: definition and operational criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Expression profiling using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

Prostate cancer chemoprevention: Strategies for designing efficient clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901416-9

7 January 2021

10.1016/S0090-4295(01)01416-9

Identifiers

DOI

1 reference

2 August 2017

1 reference